577 related articles for article (PubMed ID: 18028030)
1. Physiologically based approaches towards the prediction of pharmacokinetics: in vitro-in vivo extrapolation.
De Buck SS; Mackie CE
Expert Opin Drug Metab Toxicol; 2007 Dec; 3(6):865-78. PubMed ID: 18028030
[TBL] [Abstract][Full Text] [Related]
2. Development and application of physiologically based pharmacokinetic-modeling tools to support drug discovery.
Lüpfert C; Reichel A
Chem Biodivers; 2005 Nov; 2(11):1462-86. PubMed ID: 17191947
[TBL] [Abstract][Full Text] [Related]
3. Prediction of pharmacokinetics and drug-drug interactions from in vitro metabolism data.
Shou M
Curr Opin Drug Discov Devel; 2005 Jan; 8(1):66-77. PubMed ID: 15679174
[TBL] [Abstract][Full Text] [Related]
4. Prediction of human pharmacokinetics using physiologically based modeling: a retrospective analysis of 26 clinically tested drugs.
De Buck SS; Sinha VK; Fenu LA; Nijsen MJ; Mackie CE; Gilissen RA
Drug Metab Dispos; 2007 Oct; 35(10):1766-80. PubMed ID: 17620347
[TBL] [Abstract][Full Text] [Related]
5. [Advances and related issues in the use of in vitro methods to predict metabolic clearance rate of new drugs].
Zhang Q; Wang GJ
Yao Xue Xue Bao; 2007 Oct; 42(10):1023-8. PubMed ID: 18229605
[TBL] [Abstract][Full Text] [Related]
6. Prediction of human pharmacokinetics - renal metabolic and excretion clearance.
Fagerholm U
J Pharm Pharmacol; 2007 Nov; 59(11):1463-71. PubMed ID: 17976256
[TBL] [Abstract][Full Text] [Related]
7. Use of intrinsic clearance for prediction of human hepatic clearance.
Chao P; Uss AS; Cheng KC
Expert Opin Drug Metab Toxicol; 2010 Feb; 6(2):189-98. PubMed ID: 20073997
[TBL] [Abstract][Full Text] [Related]
8. Physiologically based pharmacokinetics (PBPK).
Espié P; Tytgat D; Sargentini-Maier ML; Poggesi I; Watelet JB
Drug Metab Rev; 2009; 41(3):391-407. PubMed ID: 19601719
[TBL] [Abstract][Full Text] [Related]
9. Application of a generic physiologically based pharmacokinetic model to the estimation of xenobiotic levels in human plasma.
Brightman FA; Leahy DE; Searle GE; Thomas S
Drug Metab Dispos; 2006 Jan; 34(1):94-101. PubMed ID: 16221756
[TBL] [Abstract][Full Text] [Related]
10. Predicting human pharmacokinetics from preclinical data.
Poggesi I
Curr Opin Drug Discov Devel; 2004 Jan; 7(1):100-11. PubMed ID: 14982153
[TBL] [Abstract][Full Text] [Related]
11. Prediction of human pharmacokinetics from preclinical information: comparative accuracy of quantitative prediction approaches.
Hosea NA; Collard WT; Cole S; Maurer TS; Fang RX; Jones H; Kakar SM; Nakai Y; Smith BJ; Webster R; Beaumont K
J Clin Pharmacol; 2009 May; 49(5):513-33. PubMed ID: 19299532
[TBL] [Abstract][Full Text] [Related]
12. Prediction of human pharmacokinetics--evaluation of methods for prediction of hepatic metabolic clearance.
Fagerholm U
J Pharm Pharmacol; 2007 Jun; 59(6):803-28. PubMed ID: 17637173
[TBL] [Abstract][Full Text] [Related]
13. Prediction of Phase I single-dose pharmacokinetics using recombinant cytochromes P450 and physiologically based modelling.
Gibson CR; Bergman A; Lu P; Kesisoglou F; Denney WS; Mulrooney E
Xenobiotica; 2009 Sep; 39(9):637-48. PubMed ID: 19480559
[TBL] [Abstract][Full Text] [Related]
14. Prediction of in vivo drug disposition from in vitro data based on physiological pharmacokinetics.
Iwatsubo T; Hirota N; Ooie T; Suzuki H; Sugiyama Y
Biopharm Drug Dispos; 1996 May; 17(4):273-310. PubMed ID: 8845471
[TBL] [Abstract][Full Text] [Related]
15. Identification of interspecies difference in hepatobiliary transporters to improve extrapolation of human biliary secretion.
Lai Y
Expert Opin Drug Metab Toxicol; 2009 Oct; 5(10):1175-87. PubMed ID: 19611403
[TBL] [Abstract][Full Text] [Related]
16. In vitro measurements of metabolism for application in pharmacokinetic modeling.
Lipscomb JC; Poet TS
Pharmacol Ther; 2008 Apr; 118(1):82-103. PubMed ID: 18374419
[TBL] [Abstract][Full Text] [Related]
17. Exploration of the African green monkey as a preclinical pharmacokinetic model: intravenous pharmacokinetic parameters.
Ward KW; Coon DJ; Magiera D; Bhadresa S; Nisbett E; Lawrence MS
Drug Metab Dispos; 2008 Apr; 36(4):715-20. PubMed ID: 18227143
[TBL] [Abstract][Full Text] [Related]
18. Application of IVIVE and PBPK modeling in prospective prediction of clinical pharmacokinetics: strategy and approach during the drug discovery phase with four case studies.
Chen Y; Jin JY; Mukadam S; Malhi V; Kenny JR
Biopharm Drug Dispos; 2012 Mar; 33(2):85-98. PubMed ID: 22228214
[TBL] [Abstract][Full Text] [Related]
19. Physiologically based modelling and prediction of drug interactions.
Bois FY
Basic Clin Pharmacol Toxicol; 2010 Mar; 106(3):154-61. PubMed ID: 19912164
[TBL] [Abstract][Full Text] [Related]
20. Mechanistic pharmacokinetic modeling for the prediction of transporter-mediated disposition in humans from sandwich culture human hepatocyte data.
Jones HM; Barton HA; Lai Y; Bi YA; Kimoto E; Kempshall S; Tate SC; El-Kattan A; Houston JB; Galetin A; Fenner KS
Drug Metab Dispos; 2012 May; 40(5):1007-17. PubMed ID: 22344703
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
